An overview of stimuli-induced pulsatile drug delivery systems

International Journal of PharmTech Research

Volumn 2, Issue 4, 2010, Pages 2364-2378

  Ashwini Kumar, G ^a   Bhat, Amit ^a   Prasanna Lakshmi, A ^a   Reddy, Karnaker ^a  

^a Bharat Institute of Technology Pharmacy   (India)

Author keywords

Electro responsive; Pulsatile release; Thermo responsive; Triggered release

Indexed keywords

ALKYLATING AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIMETABOLITE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; GLUCOSE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METHYLPHENIDATE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONYLUREA; VINCA ALKALOID;

CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ELECTROMAGNETIC FIELD; INFLAMMATION; INSULIN RELEASE; LIGHT; PH; PULSATILE DRUG RELEASE; REVIEW; TEMPERATURE; ULTRASOUND;

EID: 78249264102     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Anita Lalwani and D. D. Santani, Pulsatile Drug Delivery Systems, 2007; 69(4): 489-497.
2. Barbarant G, Prank K. Pulsatile patterns in hormone secretion. Trends Endocrinol Metabol, 1992; 183-190.
3. Siegel RA, Pitt CG. A strategy for oscillatory drug release: general scheme and simplified theory. J Control Release 1995; 173-188.
4. Medlicott, NJ, Tucker IG. Pulsatile release from subcutaneous implants. Adv Drug Del Rev 1999; 139-149.
5. Dr. Gopi Venkatesh, Pharmaceutical Formulation and Quality, Eurand, June/July 2005, pp. 1.
6. Sachin Survase and Neeraj Kumar, Pulsatile Drug Delivery: Current Scenario, 2007; Vol. 8: No. 2.
7. Anil K. Anal, Stimuli-induced Pulsatile or Triggered Release Delivery Systems for Bioactive Compounds, 2006; Vol. 1: 83-90.
8. Siegel RA and Pitt CG, 1995; J. Control. Rel. 33:173-188.
9. Lee, DY., Chen, C. M.: US20006103263, 2000.
10. Okano T, Bae YH, Jacobs H, Kim SW. Thermally on-off switching polymers for drug permeation and release. J Control Release 1990; 255-265.
11. Bae YH, Okano T, Kim SW. "On-off" thermocontrol of solute transport. I: temperature dependence of swelling of Nisopropylacrylamide networks modified with hydrophobic components in water. Phram Res 1991; 8 (4): 531-537.
12. Bae YH, Okano T, Kim SW. "On-off" thermocontrol of solute transport. II: temperature dependence of swelling of Nisopropylacrylamide networks modified with hydrophobic components in water. Phram Res 1991; 8 (5): 624-628.
13. Okano, T., Yuim N., Yokoyama, M. and Yoshida, R., Advances in Polymerics Systems for Drug Delivery, Gordon and Breach, Yverdon, Switzerland, 1994.
14. Dinaravand RD, Emanele A. 1995 Use of thermoresponsive hydrogels for on-off release of molecules. J Control Release, 1995; 221-227.
15. Gutowska A. Bark JS, Kwon IC, Bae YH, Kim SW. Squeezing hydrogels for controlled oral drug delivery. J Control Release, 1997; 141-148.
16. R. Yoshida, K. Uchida, Y. Kaneko, K. Sakai, A. Kikuchi, Y. Sakurai, T. Okano, Comb-type grafted hydrogels with rapid temperature responses, Nature, 1995; 374 (6519): 240-242.
17. L. C. Dong, A. S. Hoffman, Synthesis and application of thermally reversible heterogels for drug delivery, J. Control. Release, 1990; 13: 21-31.
18. Kaneko Y, Sakai K, Kikuchi A, Yoshida R, Sakurai Y, Okano T. Influence of freely mobile grafted chain length on dynamic properties of comb-type grafted poly(N-isopropylacrylamide) hydrogels. Macromolecules, 1995; 7717-7723.
19. T. Okano, Y. H. Bae, H. Jacobs, S. W. Kim, Thermally on-off switching polymers for drug permeation and release, J. Control. Release, 1990; 11: 255-265.
20. E. Sato-Matsuo, T. Tanaka, Kinetics of discontinuous volume-phase transition of gels, J. Chem. Phys., 1988; 89 (3): 1695-1703.
21. O. Hirasa, Y. Morishita, R. Onomura, H. Ichijo, A. Yamauchi, Preparation and mechanical properties of thermoresponsive fibrous hydrogels made from poly(vinyl methyl ethers, Koubunshi Ronbunshu, 1989; 46 (11): 661-665.
22. B. G. Kabra, S. H. Gehrke, Synthesis of fast response, temperature-sensitive poly(N-isopropylacrylamide) gel, Polym. Commun., 1991; 32 (11): 322-323.
23. X. S. Wu, A. S. Hoffman, Synthesis and characterization of thermally reversible macroporous poly(N-isopropylacrylamide) hydrogels, J. Polym. Sci. A, 1992; 30: 2121-2129.
24. R. Kishi, O. Hirasa, H. Ichijo, Fast responsive poly(N-isopropylacrylamide) hydrogels prepared by 7-ray irradiation, Polym. Gels Networks, 1997; 5: 145-151.
25. J. Chen, H. Park, K. Park, Synthesis of superporous hydrogels: Hydrogels with fast swelling and superabsorbent properties, J. Biomed. Mater. Res., 1999; 44 (1): 53-62.
26. Oh, K. S., Han, S. K., Choi, Y. W., Lee, J. H., Lee, J. Y. and Yuk, S. H., Biomaterials, 2004; 25: 2393.
27. Fisher, J. P., US patent No., US6733788, 2004.
28. Mebride, J. F., Gehrker, S. H., Fisher, J. P., US patent No., US0015712, 2002.
29. K. Kataoka, A. Harada, Y. Nagasaki, Block copolymer micelles for drug delivery: design, characterization and biological significance, Adv. Drug Deliv., 2001; Rev. 47: 113-131.
30. Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res., 1986; 46: 6387-6392.
31. J. E. Chung, M. Yokoyama, M. Yamato, T. Aoyagi, Y. Sakurai, T. Okano, Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(Nisopropylacrylamide) and poly(butyl methacrylate), J. Control. Release, 1999; 62: 115-127.
32. J. E. Chung, M. Yokoyama, T. Okano, Inner core segment design for drug delivery control of thermo-responsive polymeric micelles, J. Control. Release, 2000; 65: 93-103.
33. F. Kohori, K. Sakai, T. Aoyagi, M. Yokoyama, Y. Sakurai, T. Okano, Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide- p-DL-lactide), J. Control. Release, 1998; 55: 87-98.
34. F. Kohori, K. Sakai, T. Aoyagi, M. Yokoyama, M. Yamato, Y. Sakurai, T. Okano, Control of adriamycin cytotoxic activity using thermally responsive polymeric micelles composed of poly(Nisopropylacrylamide- co-N, N-dimethylacrylamide)- p-poly(D, L-lactide), Colloids Surfaces B: Biointerfaces, 1999; 16: 195-205.
35. Jun Akimoto, Masamichi Nakayama, Kiyotaka Sakai and Teruo Okano, Temperature-Induced Intracellular Uptake of Thermoresponsive Polymeric Micelles, 2009; 10 (6): pp 1331-1336
36. K. Ishihara, M. Kobayashi, I. Shinohara, Control of insulin permeation through a polymer membrane with responsive function for glucose, Makromol. Chem. Rapid Commun., 1983; 4: 327-331.
37. J. Kost, T. A. Horbett, B. D. Ratner, M. Sungh, Glucose-sensitive membranes containing glucose oxidase: Activity, swelling, and permeability studies, J. Biomed. Mater. Res., 1985; 19: 1117-1133.
38. G. Albin, T. A. Horbett, B. D. Ratner, Glucose sensitive membranes for controlled delivery of insulin: insulin transport studies, J. Control. Release, 1985; 2: 153-164.
39. Obaidat, A. A. and Park, K. Biomaterials, 1997; 18: 801.
40. Qui, Y. and Park, K., Adv. Drug Deliv. Rev., 2001; 53: 321.
41. S. W. Kim, C. M. Pai, K. Makino, L. A. Seminoff, D. L. Holmberg, J. M. Gleeson, D. E. Wilson, E. J. Mack, Self-regulated glycosylated insulin delivery, J. Control. Release, 1990; 11: 193-201.
42. K. Makino, E. J. Mack, T. Okano, S. W. Kim, A microcapsule self-regulating delivery system for insulin, J. Control. Release, 1990; 12: 235-239.
43. Mastiholimath VS, Dandagi PM, Jain SS, et al., 2007; Int. J. Pharm., 328: 49-56
44. N. Yui, T. Okano, Y. Sakurai, Inflammation responsive degradation of crosslinked hyaluronic acid gels, J. Control. Release 1992; 22: 105-116.
45. N. Yui, J. Nihira, T. Okano, Y. Sakurai, Regulated release of drug microspheres from inflammation responsive degradable matrices of crosslinked hyaluronic acid, J. Control. Release 1993; 25: 133-143.
46. T. Miyata, N. Asami, T. Uragami, A reversibly antigen-responsive hydrogel, Nature 1999; 399: 766-769.
47. T. Miyata, N. Asami, T. Uragami, Preparation of an antigen-sensitive hydrogel using antigen-antibody bindings, Macromolecules 1999; 32: 2082-2084.
48. Kibat, P. G., Igari, Y., Wheatley, M. A., Eisen, H. N. and Langer, R., FASEB J., 1990; 4: 2533.
49. Igari, Y., Kibat, P. G. and Langer, R., J. Control. Release, 1990; 14: 263.
50. B. Berner, S. M. Dinh, Electronically assisted drug delivery: an overview, in: B. Berner, S. M. Dinh (Eds.), Electronically Controlled Drug Delivery, CRC Press, Boca Raton, FL, 1998; pp. 3-7.
51. R. Kishi, M. Hara, K. Sawahata, Y. Osada, Conversion of chemical into mechanical energy by synthetic polymer gels (chemomechanical system), in: D. DeRossi, K. Kajiwara, Y. Osada, A. Yamauchi (Eds.), Polymer Gels- Fundamentals and Biomedical Applications, Plenum Press, New York, 1991; pp. 205-220.
52. I. C. Kwon, Y. H. Bae, T. Okano, B. Berner, S. W. Kim, Stimuli sensitive polymers for drug delivery systems, Makromol. Chem. Macromol. Symp., 1990; 33: 265-277.
53. I. C. Kwon, Y. H. Bae, S. W. Kim, Electrically erodible polymer gel for controlled release of drugs, Nature, 1991; 354: 291-293.
54. I. C. Kwon, Y. H. Bae, T. Okano, S. W. Kim, Drug release from electric current sensitive polymers, J. Control. Release, 1991; 17: 149-156.
55. Murdan, S., J. Control. Release, 2003; 92: 1.
56. Yuk, S. H., Cho, S. H. and Lee, H. B., Pharm. Res., 1992; 9: 955.
57. Kim, S. Y. and Lee, Y. M., J. Appl. Polym. Sci., 1999; 74: 1752.
58. Hsieh, D. S. T., Langer, R. and Folkman, J., Proc. Natl. Acad. Sci, USA., 1981; 78: 1863.
59. Edelman, E. R., Kost. J., Bobeck, H. and Langer, R., J. Biomed. Mater. Res., 1985; 19: 67.
60. Kost, J., Noecker, R., Kunica, E. and Langer, R., J. Biomed. Mater. Res., 1985; 19: 935.
61. Saslawski, O., Weigarten, C., Beniot, J. P. and Couvereur, P., Life Sci., 1988; 1521.
62. Handy, E. S., Ivkov, R., Ellis-Busby, D., Foreman, A., Braunhut, S. J., Gwost, D. U., Ardman, B.: US20066997863B2 (2006).
63. Levy, D., Kost, J., Meshulam, Y. and Langer, R., J. CIin lnvest., 1989; 83: 2074.
64. Kost, J., Clin. Mater., 1993; 13: 155.
65. Machluf, M. and Kost, J., J. Biomater. Sci. Polym. Ed., 1993; 5: 147.
66. Mitragotri, S., Blankschtein, D. and Langer, R., Science, 1995; 269: 850.
67. Mitragotri, S., Blankschtein, D. and Langer, R., Pharm. Res., 1996; 13: 411.
68. Byl, N. N., Phy. Ther., 1995; 75: 539.
69. Mitragotri, S., Pharm. Res., 2000; 17: 1354.
70. Kost, J., Leong, L. and Langer, R., Proc. Natl. Acad. Sci, USA., 1989; 86: 7663.
71. Supersaxo, A., Kou, J. H., Teitelbaum, P. and Maskiewicz, R., J. Control. Release, 1993; 23: 157.
72. Miyazaki, S., Hou, W. M. and Takada, M., Chem. Pharm. Bull., 1985; 33: 428.
73. Leong, K. W., Kost, J., Mathiowitz, E. and Langer, R., Biomaterials, 1986; 7: 364.
74. Kost, J., Clin. Mater., 1993; 13: 155.
75. Averitt, R. D., Westcott, S. L. and Halas, N. J., J. Opt. Soc. Amer. B., 1999; 16: 1824.
76. Averitt, R. D., Sarkar, D. and Halas, N. J., Phys. Rev. Lett., 1997; 78: 4217.
77. Lee, K. Y., Peters, M. C., Anderson, K. W. and Mooney, D. J., Nature, 408: 998.
78. Dashevsky A and Mohamad A, Int. J. pharm., 2006.
79. Bhattacharya S, Sagi AR, Gutta M, Chiruvella R, Boinpally RR. In: Li X, Jasti BR Ed, Design of controlled release drug delivery systems, McGraw-Hill Co. 2006; 405-28.